abstract |
The present invention relates to the treatment of compound formulas I-III, their preparations, and autoimmune disorders, organ transplant rejection, activated immune system related disorders, and other disorders modulated by lymphopenia or S1P receptors. For their use as pharmaceutically active immunosuppressive agents. |